1. Home
  2. PGY vs SGP Comparison

PGY vs SGP Comparison

Compare PGY & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$13.63

Market Cap

971.3M

Sector

Finance

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$23.46

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PGY
SGP
Founded
2016
2019
Country
United States
United States
Employees
518
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.3M
932.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PGY
SGP
Price
$13.63
$23.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$34.50
$45.00
AVG Volume (30 Days)
3.7M
49.1K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
N/A
Revenue Next Year
$14.39
N/A
P/E Ratio
$13.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.40
$20.15
52 Week High
$44.99
$30.56

Technical Indicators

Market Signals
Indicator
PGY
SGP
Relative Strength Index (RSI) 48.21 44.29
Support Level $10.78 $20.95
Resistance Level $15.57 $26.29
Average True Range (ATR) 0.85 1.47
MACD -0.17 0.00
Stochastic Oscillator 18.60 38.44

Price Performance

Historical Comparison
PGY
SGP

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: